PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
451,000
+8,000 (1.81%)
May 30, 2025, 3:30 PM KST

PharmaResearch Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
392,309350,115261,011194,759154,083108,746
Upgrade
Other Revenue
---0-0-0-
Upgrade
Revenue
392,309350,115261,011194,759154,083108,746
Upgrade
Revenue Growth (YoY)
39.97%34.14%34.02%26.40%41.69%29.66%
Upgrade
Cost of Revenue
107,41498,87870,75353,24645,75035,850
Upgrade
Gross Profit
284,894251,237190,258141,513108,33372,896
Upgrade
Selling, General & Admin
106,04194,67073,82858,57242,83229,604
Upgrade
Research & Development
24,63621,17615,0308,7026,7385,543
Upgrade
Other Operating Expenses
781.57618.58556.23648.65313.55240.17
Upgrade
Operating Expenses
140,778125,18798,00175,59755,84439,471
Upgrade
Operating Income
144,116126,05192,25865,91652,48933,426
Upgrade
Interest Expense
-6,544-4,634-2,987-3,830-1,314-1,787
Upgrade
Interest & Investment Income
11,67710,1747,4035,2723,7262,098
Upgrade
Currency Exchange Gain (Loss)
4,1874,955-379.95207.69155.77163.98
Upgrade
Other Non Operating Income (Expenses)
-6,127-6,0283,396-3,220124.324,338
Upgrade
EBT Excluding Unusual Items
147,309130,51799,69064,34655,18138,239
Upgrade
Gain (Loss) on Sale of Investments
-8,165-14,2384,210-5,0231,4622,907
Upgrade
Gain (Loss) on Sale of Assets
5.66-11.9236.11-113.69229.6-362.6
Upgrade
Asset Writedown
-192.1--3,231-5,161-839.66-1,246
Upgrade
Other Unusual Items
-454.59-454.59----
Upgrade
Pretax Income
138,503115,813100,70554,04856,03339,537
Upgrade
Income Tax Expense
31,83826,87023,44010,6149,2107,085
Upgrade
Earnings From Continuing Operations
106,66588,94377,26543,43446,82432,452
Upgrade
Minority Interest in Earnings
4,3093,100-713.44-2,857-134.98322.11
Upgrade
Net Income
110,97392,04376,55140,57746,68932,774
Upgrade
Net Income to Common
110,97392,04376,55140,57746,68932,774
Upgrade
Net Income Growth
45.84%20.24%88.66%-13.09%42.45%96.64%
Upgrade
Shares Outstanding (Basic)
101010101010
Upgrade
Shares Outstanding (Diluted)
111011101010
Upgrade
Shares Change (YoY)
-0.09%-2.50%5.85%-0.76%5.74%0.73%
Upgrade
EPS (Basic)
10730.388940.877571.244067.474716.623447.46
Upgrade
EPS (Diluted)
10648.938940.877487.074067.004714.883447.00
Upgrade
EPS Growth
43.78%19.42%84.09%-13.74%36.78%95.19%
Upgrade
Free Cash Flow
97,803101,70752,88342,14744,652-2,393
Upgrade
Free Cash Flow Per Share
9273.999879.605008.314224.854441.83-251.75
Upgrade
Dividend Per Share
1100.0001100.000950.000660.000600.000500.000
Upgrade
Dividend Growth
15.79%15.79%43.94%10.00%20.00%66.67%
Upgrade
Gross Margin
72.62%71.76%72.89%72.66%70.31%67.03%
Upgrade
Operating Margin
36.73%36.00%35.35%33.84%34.06%30.74%
Upgrade
Profit Margin
28.29%26.29%29.33%20.83%30.30%30.14%
Upgrade
Free Cash Flow Margin
24.93%29.05%20.26%21.64%28.98%-2.20%
Upgrade
EBITDA
158,384139,696104,25376,51862,04141,786
Upgrade
EBITDA Margin
40.37%39.90%39.94%39.29%40.27%38.42%
Upgrade
D&A For EBITDA
14,26813,64511,99610,6029,5528,360
Upgrade
EBIT
144,116126,05192,25865,91652,48933,426
Upgrade
EBIT Margin
36.73%36.00%35.35%33.84%34.06%30.74%
Upgrade
Effective Tax Rate
22.99%23.20%23.28%19.64%16.44%17.92%
Upgrade
Advertising Expenses
-29,64222,60118,3819,3395,711
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.